复方血栓通胶囊口服联合复方樟柳碱注射液局部注射治疗非增生型糖尿病视网膜病变的临床疗效
Clinical efficacy of compound thrombosis capsule combined with compound anisodine injection in the treatment of non-proliferative diabetic retinopathy
沈学成1
作者信息
- 1. 浙江省湖州市中医院 眼科,浙江 湖州 313000
- 折叠
摘要
目的 探究分析复方血栓通胶囊口服联合复方樟柳碱注射液局部注射治疗非增生型糖尿病视网膜病变的临床疗效.方法 对在浙江省湖州市中医院接受治疗的非增生型糖尿病视网膜病变患者60例进行研究,所有患者均为2014年3月~2016年5月期间入院,采用简单随机分组将其分为2组,对照组给予患者丹参注射液进行治疗,给予观察组患者复方血栓通胶囊口服联合复方樟柳碱注射液局部注射治疗,对其临床疗效与血流变指标水平情况进行比较.结果 观察组患者的临床总好转概率为93.33%,明显高于对照组(P<0.05);观察组患者的PV、HCT、KAI以及Fg水平均明显较对照组低(P<0.05).结论 复方血栓通胶囊口服联合复方樟柳碱注射液局部注射治疗非增生型糖尿病视网膜病变的临床疗效显著,值得广泛应用.
Abstract
Objective To explore the clinical efficacy of compound Xueshuantong capsule combined with compound anisodine injection in the treatment of non-proliferative diabetic retinopathy.MethodsSixty patients with non-proliferative diabetic retinopathy were enrolled in this study.All patients were enrolled from March 2014 to May 2016 and were divided into two groups by simple randomization.The control group were treated with salvia miltiorrhiza injection, and the patients were treated with compound Xueshuantong capsule combined with compound anisodine injection.The clinical efficacy and the level of hemorheology were compared.ResultsThe clinical improvement rate was 93.33% in the observation group, which was significantly higher than that in the control group (P<0.05).The PV, HCT, KAI and Fg levels in the observation group were significantly lower than those in the control group (P<0.05).ConclusionCompound Xueshuantong Capsule combined with compound anisodine injection for local injection of non-proliferative diabetic retinopathy has a significant clinical effect and is widely used.
关键词
复方血栓通胶囊/复方樟柳碱注射液/局部注射/非增生型糖尿病视网膜病变/临床疗效Key words
compound Xueshuantong capsule/compound anisodine injection/local injection/non-proliferative diabetic retinopathy/clinical efficacy引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据